Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-3.53Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2024
|% Change Since: -18.01%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call for LENZ Therapeutics was largely positive, highlighting significant milestones such as the FDA's acceptance of the NDA for LNZ100, strong Phase 3 trial results, and a robust safety profile. The company is well-positioned financially and strategically for the potential launch of LNZ100, with strong support from eye care professionals. Some financial metrics showed decreased operating expenses and increased SG&A, but these were within expected parameters as the company transitions to a pre-commercial phase.Company Guidance
During the LENZ Therapeutics' Third Quarter 2024 conference call, significant progress was highlighted, particularly regarding the New Drug Application (NDA) acceptance for LNZ100. This treatment for presbyopia achieved a PDUFA target action date of August 8, 2025. Key efficacy metrics from the Phase 3 CLARITY trials were shared, including a 71% achievement of three lines or greater near vision improvement at both 30 minutes and 3 hours, and a 40% achievement at 10 hours. Additionally, 95% of participants experienced at least two lines of near vision improvement. The safety profile of LNZ100 was noted as being well-tolerated, with 95% of adverse events classified as mild. The company's commercial readiness was discussed, with plans for a U.S. launch in Q4 2025 and ongoing infrastructure development. The potential presbyopia treatment market in the U.S. was described as substantial, targeting 128 million people and representing a $3 billion+ opportunity.FDA Acceptance of NDA for LNZ100
LENZ received FDA acceptance of NDA for LNZ100 for presbyopia treatment with a PDUFA target action date of August 8th, 2025.
Positive Phase 3 CLARITY Trial Results
LNZ100 demonstrated a rapid onset with 71% achieving three lines of near vision improvement at 30 minutes and three hours, 95% achieved at least two lines of improvement, and 69% maintained improvement after 10 hours.
Strong Safety Profile of LNZ100
LNZ100 was well-tolerated with no treatment-related serious adverse events reported over 30,000 treatment days, and 95% of adverse events were mild and transient.
Market Research Indicating Strong ECP Support
78% of eye care professionals surveyed found LNZ100 to be an attractive and safe presbyopia treatment, with 83% likely to sample and 82% likely to prescribe.
Strong Financial Position
LENZ completed a $30 million PIPE financing, ending Q3 2024 with $217.2 million in cash, cash equivalents, and marketable securities, funding the company to post-launch positive operating cash flow.
---
LENZ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LENZ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $28.65 | $32.23 | +12.50% |
| Aug 14, 2024 | $23.50 | $22.60 | -3.83% |
| May 08, 2024 | $16.18 | $15.40 | -4.82% |
| Mar 18, 2024 | $15.81 | $15.29 | -3.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does LENZ Therapeutics (LENZ) report earnings?
LENZ Therapeutics (LENZ) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is LENZ Therapeutics (LENZ) earnings time?
LENZ Therapeutics (LENZ) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LENZ EPS forecast?
Currently, no data Available
---